Abstract:Objective: To analyze the screening, diagnosis, epidemiology, pregnancy outcomes and treatment status in hepatitis C virus antibody-positive pregnant women, in order to provide clinical evidence for further improving prevention and control of maternal and infant safety. Methods: Data of 246 HCV antibody-positive pregnant women admitted to the Second Hospital of Nanjing from January 2014 to December 2019 were analyzed by epidemiological survey research method. Statistical analysis was performed according to different data using t-test, χ2 test, corrected χ2 test or Fisher's exact test. Results: 80 of 246 HCV antibody-positive women had confirmed infection before pregnancy. Of these, 85% were HCV RNA positive, and 16 became pregnant after antiviral therapy. Prenatal examination during pregnancy found that 166 cases were HCV RNA positive, and the HCV RNA positive rate was 81.93%. In the relationship between infection route and birth cohort in HCV antibody-positive pregnant women, there was a statistically significant differences in the proportions of transmission route among birth cohort (χ2=115.6, P＜0.001). With the delay of birth cohort, the proportion of infection through drug use was decreased (P＜0.001), while the proportion of acupuncture-associated infection (P=0.043) and infant hospitalization history were increased (P=0.005). Among pregnancy complications, HCV antibody-positive pregnant women in HCV RNA＜5.0 E+02 IU/ml and ≥5.0 E+02 IU/ml groups had intrahepatic cholestasis of pregnancy (χ2=4.73, P=0.030) and gestational hypertension (χ2=8.65, P=0.003), and the difference in incidence was statistically significant. Postpartum treatment strategy data analysis showed that the treatment rate was highest in the first year of postpartum, and then showed an upward trend year by year, with a statistically significant difference (χ2=17.26,P =0.004). Conclusion: Anti-HCV screening rates are lower among pregnant and reproductive age women. HCV screening should be used as an important supplementary means to strengthen maternal safety and health education management during pregnancy. Active postpartum antiviral therapy, with particularly emphasis on management within the first year after delivery, can significantly improve the treatment rate among women of child bearing age.

Serotypes, Genotypes and Levels of Hepatitis C Viremia in Pregnant Women in Taiwan.

[A Survey of the Current Status of Research on the Diagnosis and Treatment of Hepatitis C Virus Antibody-Positive Pregnant Women].

Effect of Prophylactic Antiviral Intervention on T Cell Immunity in Hepatitis B Virus-Infected Pregnant Women

[Comparison of results of two immunoassays for detection of hepatitis B surface antigen in pregnant women].

Experience with HCV Detection and Molecular Genetic Characterization among Otherwise Healthy Pregnant Women and Their Partners in the Republic of Guinea

Comparison of HBV-DNA and HBeAg As Antiviral Therapeutic Indicators among HBV-infected Pregnant Women: a Systematic Review and Meta-Analysis

Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates

Comparison of HBV-specific T cell reactivity across the pregnant, postpartum and non-pregnant women with chronic HBV infection

The ELISA method with synthetic peptides to detect the serotypes of hepatitis C virus

The Polymorphism of HLA-DR and -DQ Allelic Genes Associated with Intrahepatic Cholestasis of Pregnancy

Virological Determinants of Spontaneous Postpartum E Antigen Seroconversion and Surface Antigen Seroclearance in Pregnant Women Infected with Hepatitis B Virus.

Analysis of detection result of four prenatal infection markers of pregnant women

RAPID DETECTION OF TOXICANTS IN POTABLE WATERS BY LASER LIGHT SCATTERING ) FINAL REPORT

Hepatitis E Virus Infection and Its Associated Adverse Feto-Maternal Outcomes among Pregnant Women in Qinhuangdao, China.

The relation of the frequency and functional molecules expression on plasmacytoid dendritic cells to postpartum hepatitis in women with HBeAg-positive chronic hepatitis B virus infection

Pregnancy and fetal outcomes of chronic hepatitis C mothers with viremia in China

Kinetic Changes of Viremia and Viral Antigens of Hepatitis B Virus During and after Pregnancy.

Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years

[Correlation Between Serum HBV DNA Level and HBsAg Titer in HBeAg-positive Pregnant Women and Impact of Genomic Variability of Hepatitis B Virus Pre S/S Regions on Their Correlations].

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

Evaluation of Two Type-Specific Primers PCR Genotyping Methods of Hepatitis B Virus